Referral Management MarketSize, Share & Industry Analysis, 2026-2034By ComponentBy TypeBy Mode of DeliveryBy End UserBy Facility Type
Full title & scope — all 5 axes with their segments
Referral Management Market Size, Share & Industry Analysis, By Component (Software, Services), By Type (Inbound Referrals, Outbound Referrals), By Mode of Delivery (Cloud-based, On-premise), By End User (Providers, Payers, Other End Users), By Facility Type (Hospitals & Health Systems, Ambulatory & Specialty Clinics, Diagnostic Centers & Other Facilities), and Regional Forecast, 2026-2034
Market outlook, key takeaways, drivers and challenges for the report period.
- 01By ComponentSoftware · Services
- 02By TypeInbound Referrals · Outbound Referrals
- 03By Mode of DeliveryCloud-based · On-premise
- 04By End UserProviders · Payers · Other End Users
- 05By Facility TypeHospitals & Health Systems · Ambulatory & Specialty Clinics · Diagnostic Centers & Other Facilities
- 06By Region
Market Analysis & Outlook
Referral management refers to software platforms and associated implementation and support services that coordinate the process of directing a patient from one healthcare provider to another, tracking a referral from initiation through scheduling, clinical documentation exchange and completion. It is deployed by hospitals, health systems, specialty and ambulatory clinics, and by payers seeking to manage in-network referral patterns and reduce leakage to out-of-network providers. Buyers include provider-side care coordination and IT teams as well as payer network management functions, typically integrating the platform with existing electronic health record and claims systems.
USD 12.5 billion of revenue was recorded in the global referral management referral management market in 2025. By 2034 the figure reaches USD 34.68 billion, a compound annual growth rate of 12.01% through the forecast period, along a series that runs USD 8.31 billion in 2020, USD 11.52 billion in 2024, USD 14 billion in 2026 and USD 22.03 billion in 2030.
The component mix shifts over the period. Software is the largest line in 2025 at USD 7.77 billion, a 62.16% share, moving to USD 22.89 billion and 66% by 2034. Software grows fastest at 12.76%, taking its share from 62.16% to 66%, while Services grows slowest at 10.67%. Software take share over the period; Services give it up while still growing in absolute terms.
By type, Inbound Referrals accounts for 54% of 2025 revenue at USD 6.75 billion, reaching USD 17.34 billion and 50% by 2034. Outbound Referrals grows faster at 13.05% against 11.05%, moving from 46% of revenue to 50% by 2034. This axis divides the same revenue as the component split instead of adding to it, so the two are read together and never summed.
Geographically, 57.12% of 2025 revenue sits in North America (USD 7.14 billion rising to USD 18.03 billion) ahead of Europe at 20% and USD 2.5 billion. Middle East and Africa is smallest, at 3.2%. Europe, Asia Pacific, Latin America and Middle East and Africa gain share across the period, so growth is not distributed evenly between regions.
Coverage extends to five regions, two component lines and five segmentation axes over the full fifteen years. The 2025 total itself is arrived at by triangulating published aggregates against category proxies, not by an independent count, and the splits below are estimated on that same basis, a bound on their precision worth carrying into any use of them.
Market Size, 2020–2034
USD BillionRevenue in USD Billion. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- Revenue grows from USD 12.5 billion in 2025 to USD 34.68 billion in 2034, a compound annual rate of 12.01%, having reached USD 11.52 billion in 2024 from USD 8.31 billion in 2020.
- 62.16% of 2025 revenue sits in Software (USD 7.77 billion) and it remains the largest component line in 2034 at USD 22.89 billion and 66%.
- Against a base case of USD 34.68 billion in 2034, the study also reports a bear case at USD 31.25 billion and a bull case at USD 38.11 billion, with the assumptions behind each set out separately.
- North America holds 57.12% of global revenue in 2025 at USD 7.14 billion, the largest of the five regions tracked, and reaches USD 18.03 billion by 2034.
- 90.06% of North America's base-year revenue comes from the United States alone: USD 6.43 billion in 2025, rising to USD 16.05 billion by 2034, which is why it is that region's worked example.
- The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and five segmentation axes separately, with revenue, share and a growth rate for every line in each year.
Market Trends
Revenue Share, By by component
Base year 2025Software leads with 62.2% of by component segment revenue.
Share of by component segment revenue, most recent base year.
Read across the forecast period, the global referral management referral management market shows movement in three places: component composition, regional weight, and the 12.01% rate applied to the whole.
All three are changes in mix, not in direction: nothing contracts, and the movement is in which lines and regions absorb the new revenue.
Composition shifts on the component axis. Software grows at 12.76% across 2026-2034 against 10.67% for Services, the widest spread on the component axis. By 2034 the two sit at 66% and 34% of revenue, against 62.16% and 37.84% in 2025. In absolute terms Software rises from USD 7.77 billion to USD 22.89 billion, while Services rises from USD 4.73 billion to USD 11.79 billion. Both grow; the gap is wide enough to reshape the mix inside a single forecast window.
Growth concentrates in Europe, Asia Pacific, Latin America and Middle East and Africa. Europe moves from 20% of revenue in 2025 to 20.01% in 2034, worth USD 2.5 billion rising to USD 6.94 billion; Asia Pacific moves from 15.52% of revenue in 2025 to 20.01% in 2034, worth USD 1.94 billion rising to USD 6.94 billion; Latin America moves from 4.16% of revenue in 2025 to 4.5% in 2034, worth USD 0.52 billion rising to USD 1.56 billion; Middle East and Africa moves from 3.2% of revenue in 2025 to 3.49% in 2034, worth USD 0.4 billion rising to USD 1.21 billion. The remaining regions grow in absolute terms while giving up share: North America at 57.12% moving to 51.99%. Revenue added in this market is therefore concentrating geographically instead of spreading evenly, and a participant weighted toward a share-losing region grows more slowly than the market even while its own revenue climbs.
Growth compounds at 12.01% without a step change. The market moves through USD 8.31 billion in 2020, USD 11.52 billion in 2024, USD 12.5 billion in 2025, USD 14 billion in 2026, USD 22.03 billion in 2030 and USD 34.68 billion in 2034. There is no discontinuity to time, and 12.01% forecast growth against 8.52% historical means the trend continues and does not turn. That moves the planning question away from timing a turn and onto the component and regional mixes, where the actual movement is.
Market Growth Factors
Growth is concentrated in Software
Market Drivers
3- 01Growth is concentrated in Software
12.76% growth in Software, against 12.01% for the market as a whole, moves it from USD 7.77 billion and 62.16% of revenue in 2025 to USD 22.89 billion and 66% in 2034. Nothing else on the axis grows as fast (Services manages 10.67%) so the blended 12.01% is carried by this one line instead of shared across them. Where a supplier sits on this axis therefore decides whether it grows with the market or below it.
- 02North America carries 57.12% of the base and keeps growing
The largest regional base is North America: USD 7.14 billion in 2025 at 57.12% of the global total, USD 18.03 billion by 2034, still 51.99%. Behind it, Europe holds 20%; USD 2.5 billion rising to USD 6.94 billion. Most of the base and most of the growth sit in those two, and a plan spread evenly across regions therefore over-invests outside them.
- 03The trend is already in the record
USD 8.31 billion in 2020, USD 11.52 billion in 2024 and USD 12.5 billion in 2025: 8.52% compound growth before the forecast period even begins. From there the forecast carries 12.01% through to USD 34.68 billion in 2034. Fifteen years of unbroken growth in the series means the forecast rests on a demonstrated trajectory, not a projected turnaround, and it is why the 12.01% rate is applied flat across the whole period instead of ramped through it.
Growth drivers
| # | Growth driver | Impact | Gross contribution (Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Value-based care contracts and referral leakage reduction mandates | High | +6.5 | Medium | High | High |
| 2 | Interoperability and FHIR-based EHR integration standards | High | +5.2 | High | Medium | Medium |
| 3 | Growth in specialist referral volume from aging and chronic-disease populations | Medium-High | +4.1 | Medium | Medium | Medium |
| 4 | Cloud and SaaS migration of care-coordination platforms | Medium-High | +3.3 | High | Medium | Low |
| 5 | Payer network management and prior-authorization automation | Medium | +2.4 | Low | Medium | High |
| 6 | Others | Low | +4.48 | Low | Low | Low |
| Total | +25.98 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Integration complexity across fragmented EHR systems | Medium | −1.8 | High | Medium | Low |
| 2 | Data privacy and interoperability compliance costs | Medium | −1.2 | Medium | Medium | Medium |
| 3 | Budget constraints among smaller independent practices | Low | −0.8 | Medium | Low | Low |
| Total | −3.8 | |||||
Drivers contribute 25.98 Billion and restraints remove 3.8 Billion, a net 22.18 Billion, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
Separate the 12.01% into its parts and three show up: an already-large base compounding, the component mix moving toward its faster lines, and regional growth landing unevenly.
Restraining Factors
What holds the forecast back
Market Restraints
2- 01What holds the forecast back
Bear case assumes budget constraints at independent and mid-size practices delay platform upgrades and slow the shift away from fax- and phone-based referral coordination. On that assumption 2034 revenue lands at USD 31.25 billion against the USD 34.68 billion base case, from the same USD 12.5 billion 2025 starting point.
- 02Services holds the blended rate down
Services carries 37.84% of 2025 revenue at USD 4.73 billion but compounds at 10.67% against 12.01% for the market, taking its share to 34% by 2034 even as revenue rises to USD 11.79 billion. Because it carries that much of the base, its pace holds the blended rate down more than any faster line lifts it.
Market Opportunities
Where the forecast could be beaten
Market Opportunities
2- 01Where the forecast could be beaten
The upside path assumes bull case assumes interoperability mandates and payer network-management adoption move faster than the base case, pulling forward cloud migration and shortening the sales cycle for larger health systems. It ends 2034 at USD 38.11 billion against a USD 34.68 billion base case, off the same USD 12.5 billion base year.
- 02The opening is on the component axis, not the regional one
Share on the component axis moves toward Software, from 62.16% in 2025 to 66% in 2034, on 12.76% growth against the market's 12.01% and revenue rising from USD 7.77 billion to USD 22.89 billion. Taking position there does not require displacing whoever holds Software, which is the harder and more expensive fight.
Market Challenges
Concentration on the component axis
Market Challenges
2- 01Concentration on the component axis
One line dominates: Software, at 62.16% of revenue in 2025 and 66% in 2034, worth USD 7.77 billion and USD 22.89 billion. Anything that changes demand for it changes the headline number; nothing else on the axis carries that weight.
- 02Single-country exposure in North America
Of North America's USD 7.14 billion in 2025, USD 6.43 billion (90.06%) comes from the United States alone, rising to USD 16.05 billion by 2034. Regional totals therefore move largely with one country's demand, so a regional forecast is more exposed to single-country conditions than its size alone suggests.
Segmentation Analysis
5 axesfive segmentation axes are reported; by component, by type, mode of delivery, end user and facility type. Each axis cuts the same total revenue along a different commercial dimension, so the splits are alternative views of one market, not additions to it.
Two component lines are reported. One of them takes share over the forecast period and the other gives it up, though every line grows in absolute terms between 2025 and 2034.
By Component · 2 segments
Scale and Growth Sit in the Same Line on the Component Axis: Software
- Largest Software · 62.2%
- Fastest Software · 12.8%
- Moves most Software · +3.8 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Software | $7.77B | 62.2% | $22.89B | 66%+3.8 | 12.8% |
| Services | $4.73B | 37.8% | $11.79B | 34%-3.8 | 10.7% |
Software leads because platforms that automate referral routing, tracking and documentation exchange deliver the clearest return on investment and scale across a health system's full provider network. Software also grows fastest as cloud subscription adoption widens the addressable buyer base beyond large health systems to smaller practices that previously relied on manual, fax-based referral coordination. The order does not change: Software is still largest in 2034, and what moves is how much it holds. This is the axis the estimation prices in full, year by year, and the one the regional chapters cut against.
By Type · 2 segments
Scale in Inbound Referrals and Growth in Outbound Referrals Define the Type Axis
- Largest Inbound Referrals · 54%
- Fastest Outbound Referrals · 13.1%
- Moves most Inbound Referrals · -4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Inbound Referrals | $6.75B | 54% | $17.34B | 50%-4 | 11.1% |
| Outbound Referrals | $5.75B | 46% | $17.34B | 50%+4 | 13.1% |
Inbound referrals lead because specialists and receiving facilities are the primary point where referral-tracking software is first adopted, to manage incoming volume and reduce scheduling delays. Outbound referrals grow fastest as primary care networks and payers increasingly track referrals leaving their network, driven by value-based contracts that reward keeping patients in-network. By 2034 Inbound Referrals is still ahead, making this a shift in weight, not a change of leader.
By Mode of Delivery · 2 segments
Scale and Growth Sit in the Same Line on the Mode of delivery Axis: Cloud-based
- Largest Cloud-based · 68%
- Fastest Cloud-based · 14.1%
- Moves most Cloud-based · +12 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Cloud-based | $8.50B | 68% | $27.74B | 80%+12 | 14.1% |
| On-premise | $4B | 32% | $6.94B | 20%-12 | 6.3% |
Cloud-based deployment leads and grows fastest because it lowers upfront implementation cost, supports multi-site health systems and integrates more readily with cloud-hosted electronic health record and payer systems. On-premise deployment persists mainly among larger hospital systems with existing data-center infrastructure and stricter internal data-residency requirements that slow migration. By 2034 Cloud-based is still ahead, making this a shift in weight, not a change of leader.
By End User · 3 segments
Providers Held the Dominant Share of the End user Segment in 2025
- Largest Providers · 66%
- Fastest Payers · 13.7%
- Moves most Providers · -4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Providers | $8.25B | 66% | $21.50B | 62%-4 | 11.2% |
| Payers | $3.38B | 27% | $10.75B | 31%+4 | 13.7% |
| Other End Users | $0.87B | 7% | $2.43B | 7% | 12.1% |
Providers lead because hospitals, health systems and clinics are the direct point of referral initiation and receipt, and were the first buyers of referral coordination software. Payers grow fastest as network management and prior-authorization automation become priorities for controlling referral leakage and containing out-of-network spending under value-based contracts. By 2034 Providers is still ahead, making this a shift in weight, not a change of leader.
By Facility Type · 3 segments
Scale in Hospitals & Health Systems and Growth in Ambulatory & Specialty Clinics Define the Facility type Axis
- Largest Hospitals & Health Systems · 58%
- Fastest Ambulatory & Specialty Clinics · 13.8%
- Moves most Hospitals & Health Systems · -5 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Hospitals & Health Systems | $7.25B | 58% | $18.38B | 53%-5 | 10.9% |
| Ambulatory & Specialty Clinics | $4B | 32% | $12.83B | 37%+5 | 13.8% |
| Diagnostic Centers & Other Facilities | $1.25B | 10% | $3.47B | 10% | 12% |
Hospitals and health systems lead because they manage the widest referral networks and have the budget and IT infrastructure to deploy enterprise-wide coordination platforms. Ambulatory and specialty clinics grow fastest as care shifts toward outpatient settings and independent practices adopt lighter-weight, cloud-hosted referral tools to stay connected to larger networks. The order does not change: Hospitals & Health Systems is still largest in 2034, and what moves is how much it holds.
Regional Insights
Regional Revenue Share
Base year 2025Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The largest region covered, and the one giving up the most — 5.1 points of share move elsewhere by 2034, while revenue still grows 2.5×.
- Rank 1 of 5
- 2025 share 57.1%
- By 2034 52%
- Revenue $7.14B → $18.03B
In North America, 57.12% of global revenue puts 2025 at USD 7.14 billion with USD 18.03 billion projected for 2034. It is a dominant region on this axis, first by revenue throughout the period.
By 2034 the share stands at 51.99%, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
Segment composition follows the global pattern: Software largest at 62.16% of 2025 revenue, Software fastest at 12.76%. Revenue for North America is broken out by every segmentation axis and by country in the full report.
United States
Sets the pace for North America at 90.1% of it, growing 2.5×.
- In region 1 of 2
- Of region 90.1%
- Of global 51.4%
- Revenue $6.43B → $16.05B
USD 6.43 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 16.05 billion by 2034. Because it is 90.06% of the region in the base year, North America's totals move with this one country instead of a spread of them. Regional revenue of USD 7.14 billion in 2025 and USD 18.03 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
The component pattern in the United States is the global one: 62.16% of 2025 revenue in Software, 66% by 2034, against 12.76% growth in Software taking it from 62.16% to 66%. Because the country carries 90.06% of North America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. The full report reports the United States by component separately.
Referral management platforms in the United States sit at the boundary between clinical software and administrative health information technology, and their regulatory treatment depends on function. Where the software merely coordinates scheduling, documentation, and communication between providers without offering diagnostic or treatment recommendations, it generally falls outside the Food and Drug Administration's device definition under the clinical decision support carve-outs in federal law. Any referral tool that stores, transmits, or exchanges protected health information must still meet the Health Insurance Portability and Accountability Act's privacy and security requirements, and platforms seeking certified status for interoperability and information blocking compliance are assessed against the Office of the National Coordinator's Health IT Certification Program criteria.
Competition in the United States runs between the suppliers this study tracks: GetWellNetwork (US), Epic Systems Corporation (US), Cerner Corporation (US), CarePort Health (US), eHealth Technologies, Inc. (US), Optum, Inc. (US), Change Healthcare (US), ReferralMD (US), Kyruus (US), Eceptionist (US), Persistent Systems (India), HealthViewX (US), Conifer Health Solutions, LLC (US), EcoSoft Health (US), DentalCareLinks (US), BlockitNow, Inc. (US), Cloudmed (US), EZ Referral (Canada), ReferWell (US), Arcadia (US), HealthWare Systems (US), Netsmart Technologies, Inc. (US), Advanced (UK), Innovaccer, Inc. (US), Lightbeam Health Solutions (US), MDfit (US), and Medcohere Inc. (US), Allscripts Healthcare Solutions, Inc. and SCI Solutions. Software is where the volume is, at 62.16% of 2025 revenue, and it is growing fastest as well at 12.76%. Country-level positioning and shares for each of these companies are part of the full report, not of this summary.
Canada
2nd-largest in North America, growing 2.8×.
- In region 2 of 2
- Of region 9.9%
- Of global 5.7%
- Revenue $0.71B → $1.98B
Canada is sized at USD 0.71 billion in 2025, rising to USD 1.98 billion by 2034; 5.68% of global revenue and 9.94% of North America. It is reported separately from the United States across every segmentation axis in the full report.
Europe Market Analysis
The 2nd-largest region covered, holding its share flat through 2034, while revenue still grows 2.8×.
- Rank 2 of 5
- 2025 share 20%
- By 2034 20%
- Revenue $2.50B → $6.94B
In Europe, 20% of global revenue puts 2025 at USD 2.5 billion on the way to USD 6.94 billion by 2034. It is a leading region on this axis, second by revenue throughout the period.
20.01% of global revenue sits here by 2034, up from the 2025 level, so the region grows faster than the market's 12.01% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
The component mix reported at global level applies here, with Software the largest line at 62.16% of 2025 revenue and Software the fastest-growing at 12.76%. Per-axis and per-country detail for Europe sits in the full report.
Germany
The largest market in Europe, growing 2.8×.
- In region 1 of 3
- Of region 24%
- Of global 4.8%
- Revenue $0.60B → $1.67B
Germany is the largest market within Europe, generating USD 0.6 billion in 2025 and projected to reach USD 1.67 billion by 2034. At 24% of the region in 2025 it leads, but a majority of Europe's revenue is generated in other markets. Set against USD 2.5 billion and USD 6.94 billion for the region, it is why this market, and not a smaller one, is the one reported in full.
Germany buys along the same lines as the market globally; Software first at 62.16% of 2025 revenue and 66% in 2034, Software fastest at 12.76% on a share moving from 62.16% to 66%. Because the country carries 24% of Europe, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Revenue by component for Germany is reported separately in the full report.
In Germany, referral management software is assessed under the framework that applies across the European Union, with classification turning on whether the tool performs functions that affect clinical decision-making or patient management in a manner that meets the definition of a medical device. Software qualifying as a medical device must carry conformity marking under the Medical Device Regulation, with technical documentation, a quality management system, and post-market surveillance maintained by the manufacturer. The Federal Institute for Drugs and Medical Devices oversees market surveillance domestically, while purely administrative referral tools that do not influence diagnosis or treatment instead fall under general data protection obligations for handling patient information. Digital health applications seeking reimbursement follow the fast-track pathway administered by that same federal institute.
The suppliers tracked in this study (GetWellNetwork (US), Epic Systems Corporation (US), Cerner Corporation (US), CarePort Health (US), eHealth Technologies, Inc. (US), Optum, Inc. (US), Change Healthcare (US), ReferralMD (US), Kyruus (US), Eceptionist (US), Persistent Systems (India), HealthViewX (US), Conifer Health Solutions, LLC (US), EcoSoft Health (US), DentalCareLinks (US), BlockitNow, Inc. (US), Cloudmed (US), EZ Referral (Canada), ReferWell (US), Arcadia (US), HealthWare Systems (US), Netsmart Technologies, Inc. (US), Advanced (UK), Innovaccer, Inc. (US), Lightbeam Health Solutions (US), MDfit (US), and Medcohere Inc. (US), Allscripts Healthcare Solutions, Inc. and SCI Solutions) compete in Germany across the component lines above. Volume and growth sit in the same line, Software, at 62.16% of 2025 revenue and 12.76% growth. That makes Europe a 20% share of 2025 global revenue, USD 2.5 billion rising to USD 6.94 billion, for any supplier deciding where to concentrate.
United Kingdom
2nd-largest in Europe, growing 2.8×.
- In region 2 of 3
- Of region 20%
- Of global 4%
- Revenue $0.50B → $1.39B
The United Kingdom is sized at USD 0.5 billion in 2025, rising to USD 1.39 billion by 2034; 4% of global revenue and 20% of Europe. It is reported separately from Germany across every segmentation axis in the full report.
France
3rd-largest in Europe, growing 2.7×.
- In region 3 of 3
- Of region 15.2%
- Of global 3%
- Revenue $0.38B → $1.04B
3.04% of global revenue is generated in France; USD 0.38 billion in 2025, reaching USD 1.04 billion in 2034, and 15.2% of Europe.
Asia Pacific Market Analysis
The 3rd-largest region covered — it picks up 4.5 points of share by 2034, while revenue still grows 3.6×.
- Rank 3 of 5
- 2025 share 15.5%
- By 2034 20%
- Revenue $1.94B → $6.94B
15.52% of the global referral management referral management market sits in Asia Pacific in 2025, worth USD 1.94 billion with USD 6.94 billion projected for 2034. That makes it the third-largest region covered, in 2025 and again in 2034.
20.01% of global revenue sits here by 2034, up from the 2025 level, at a pace above the 12.01% global rate, so this region warrants separate treatment and should not be scaled off the total.
Segment composition follows the global pattern: Software largest at 62.16% of 2025 revenue, Software fastest at 12.76%. The full report breaks Asia Pacific out along every axis and by country.
Japan
The largest market in Asia Pacific, growing 3.6×.
- In region 1 of 3
- Of region 27.8%
- Of global 4.3%
- Revenue $0.54B → $1.94B
USD 0.54 billion of Asia Pacific's 2025 revenue is generated in Japan, the region's largest market, reaching USD 1.94 billion by 2034. It accounts for 27.84% of regional revenue in the base year, the largest single share without dominating the region outright. The region itself runs USD 1.94 billion to USD 6.94 billion over the same period, and this is the market carrying the country-level detail in the full report.
Composition here matches the global split: the largest line is Software at 62.16% of 2025 revenue, easing to 66% by 2034, and the fastest is Software at 12.76%, from 62.16% to 66%. Its 27.84% weight in Asia Pacific means those movements carry straight into the regional totals. Per-component revenue for Japan appears on its own in the full report.
Japan regulates software used in healthcare through the Pharmaceuticals and Medical Devices Act, administered by the Ministry of Health, Labour and Welfare together with the Pharmaceuticals and Medical Devices Agency. Referral management tools that limit themselves to scheduling, documentation, and communication between providers typically sit outside the definition of a regulated medical device, since they do not perform diagnostic or therapeutic functions. Where a platform incorporates decision-support features that influence a clinician's judgment, it may instead require review and approval as software as a medical device before it can be marketed. Any system handling patient information must also comply with the Act on the Protection of Personal Information, and vendors commonly align with recognized health data exchange standards to support interoperability across providers.
The suppliers tracked in this study (GetWellNetwork (US), Epic Systems Corporation (US), Cerner Corporation (US), CarePort Health (US), eHealth Technologies, Inc. (US), Optum, Inc. (US), Change Healthcare (US), ReferralMD (US), Kyruus (US), Eceptionist (US), Persistent Systems (India), HealthViewX (US), Conifer Health Solutions, LLC (US), EcoSoft Health (US), DentalCareLinks (US), BlockitNow, Inc. (US), Cloudmed (US), EZ Referral (Canada), ReferWell (US), Arcadia (US), HealthWare Systems (US), Netsmart Technologies, Inc. (US), Advanced (UK), Innovaccer, Inc. (US), Lightbeam Health Solutions (US), MDfit (US), and Medcohere Inc. (US), Allscripts Healthcare Solutions, Inc. and SCI Solutions) compete in Japan across the component lines above. One line leads on both counts here: Software holds 62.16% of 2025 revenue and compounds fastest at 12.76%. That makes Asia Pacific a 15.52% share of 2025 global revenue, USD 1.94 billion rising to USD 6.94 billion, for any supplier deciding where to concentrate.
China
2nd-largest in Asia Pacific, growing 3.6×.
- In region 2 of 3
- Of region 25.3%
- Of global 3.9%
- Revenue $0.49B → $1.74B
Within Asia Pacific, China accounts for 25.26% of regional revenue and 3.92% of the global total, worth USD 0.49 billion in 2025 and USD 1.74 billion by 2034.
India
3rd-largest in Asia Pacific, growing 3.6×.
- In region 3 of 3
- Of region 14.9%
- Of global 2.3%
- Revenue $0.29B → $1.04B
India is sized at USD 0.29 billion in 2025, rising to USD 1.04 billion by 2034; 2.32% of global revenue and 14.95% of Asia Pacific. It is reported separately from Japan across every segmentation axis in the full report.
Latin America Market Analysis
The 4th-largest region covered — it picks up 0.3 points of share by 2034, while revenue still grows 3.0×.
- Rank 4 of 5
- 2025 share 4.2%
- By 2034 4.5%
- Revenue $0.52B → $1.56B
USD 0.52 billion of 2025 revenue is generated in Latin America, 4.16% of the global referral management referral management market rising to USD 1.56 billion in 2034. It is a marginal region on this axis, fourth by revenue throughout the period.
By 2034 the share has moved up to 4.5%, so the region grows faster than the market's 12.01% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
The component mix reported at global level applies here, with Software the largest line at 62.16% of 2025 revenue and Software the fastest-growing at 12.76%. Latin America is reported axis by axis and country by country in the full study.
Brazil
The largest market in Latin America, growing 3.0×.
- In region 1 of 2
- Of region 44.2%
- Of global 1.8%
- Revenue $0.23B → $0.70B
The largest single market in Latin America is Brazil, at USD 0.23 billion in 2025 and USD 0.7 billion in 2034. Its 44.23% of base-year regional revenue leads the region, though enough sits elsewhere that Latin America is not a proxy for it. Against regional totals of USD 0.52 billion in 2025 and USD 1.56 billion in 2034, it is the country the full report breaks out in detail.
Brazil buys along the same lines as the market globally; Software first at 62.16% of 2025 revenue and 66% in 2034, Software fastest at 12.76% on a share moving from 62.16% to 66%. Its 44.23% weight in Latin America means those movements carry straight into the regional totals. Brazil carries its own component breakdown in the full report.
In Brazil, oversight of health-related software rests with the National Health Surveillance Agency, which classifies medical device software according to the risk it poses to patients and the role it plays in clinical decision-making. Referral management systems that coordinate appointments, documentation, and provider communication without directing diagnosis or treatment generally fall outside that agency's device classification and instead operate under general health information rules. Platforms that incorporate clinical decision-support functions influencing patient care may require registration as medical device software before commercial distribution. Any system processing patient data must comply with the General Data Protection Law, which sets requirements for consent, security, and cross-border data transfer.
GetWellNetwork (US), Epic Systems Corporation (US), Cerner Corporation (US), CarePort Health (US), eHealth Technologies, Inc. (US), Optum, Inc. (US), Change Healthcare (US), ReferralMD (US), Kyruus (US), Eceptionist (US), Persistent Systems (India), HealthViewX (US), Conifer Health Solutions, LLC (US), EcoSoft Health (US), DentalCareLinks (US), BlockitNow, Inc. (US), Cloudmed (US), EZ Referral (Canada), ReferWell (US), Arcadia (US), HealthWare Systems (US), Netsmart Technologies, Inc. (US), Advanced (UK), Innovaccer, Inc. (US), Lightbeam Health Solutions (US), MDfit (US), and Medcohere Inc. (US), Allscripts Healthcare Solutions, Inc. and SCI Solutions are the suppliers covered in Brazil. Software is where the volume is, at 62.16% of 2025 revenue, and it is growing fastest as well at 12.76%. Weighting toward Latin America means competing for 4.16% of 2025 global revenue, a base of USD 0.52 billion moving to USD 1.56 billion across the forecast period.
Mexico
2nd-largest in Latin America, growing 2.9×.
- In region 2 of 2
- Of region 30.8%
- Of global 1.3%
- Revenue $0.16B → $0.47B
1.28% of global revenue is generated in Mexico; USD 0.16 billion in 2025, reaching USD 0.47 billion in 2034, and 30.77% of Latin America.
Middle East and Africa Market Analysis
The 5th-largest region covered — it picks up 0.3 points of share by 2034, while revenue still grows 3.0×.
- Rank 5 of 5
- 2025 share 3.2%
- By 2034 3.5%
- Revenue $0.40B → $1.21B
In Middle East and Africa, 3.2% of global revenue puts 2025 at USD 0.4 billion with USD 1.21 billion projected for 2034. By revenue it sits fifth across the study, and the ranking does not change between 2025 and 2034.
3.49% of global revenue sits here by 2034, up from the 2025 level, on growth above the market's own 12.01%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.
Segment composition follows the global pattern: Software largest at 62.16% of 2025 revenue, Software fastest at 12.76%. Per-axis and per-country detail for Middle East and Africa sits in the full report.
Saudi Arabia
The largest market in Middle East and Africa, growing 3.0×.
- In region 1 of 2
- Of region 35%
- Of global 1.1%
- Revenue $0.14B → $0.42B
35% of Middle East and Africa's base-year revenue comes from Saudi Arabia; USD 0.14 billion, rising to USD 0.42 billion by 2034. Its 35% of base-year regional revenue leads the region, though enough sits elsewhere that Middle East and Africa is not a proxy for it. Regional revenue of USD 0.4 billion in 2025 and USD 1.21 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
Composition here matches the global split: the largest line is Software at 62.16% of 2025 revenue, easing to 66% by 2034, and the fastest is Software at 12.76%, from 62.16% to 66%. Its 35% weight in Middle East and Africa means those movements carry straight into the regional totals. Revenue by component for Saudi Arabia is reported separately in the full report.
In Saudi Arabia, the Saudi Food and Drug Authority regulates software intended for medical purposes, classifying such products according to the clinical risk they present and requiring registration before a supplier may market or distribute them domestically. Referral management platforms confined to administrative coordination, scheduling, and communication between providers generally sit outside that authority's medical device classification, while tools that incorporate clinical decision-support functions affecting diagnosis or treatment fall within it and must meet the Authority's conformity and labelling requirements. Healthcare providers deploying such systems must also observe the national personal data protection law governing the handling and storage of patient information, alongside health sector standards issued by the Saudi Central Board for Healthcare Accreditation.
GetWellNetwork (US), Epic Systems Corporation (US), Cerner Corporation (US), CarePort Health (US), eHealth Technologies, Inc. (US), Optum, Inc. (US), Change Healthcare (US), ReferralMD (US), Kyruus (US), Eceptionist (US), Persistent Systems (India), HealthViewX (US), Conifer Health Solutions, LLC (US), EcoSoft Health (US), DentalCareLinks (US), BlockitNow, Inc. (US), Cloudmed (US), EZ Referral (Canada), ReferWell (US), Arcadia (US), HealthWare Systems (US), Netsmart Technologies, Inc. (US), Advanced (UK), Innovaccer, Inc. (US), Lightbeam Health Solutions (US), MDfit (US), and Medcohere Inc. (US), Allscripts Healthcare Solutions, Inc. and SCI Solutions are the suppliers covered in Saudi Arabia. Software is where the volume is, at 62.16% of 2025 revenue, and it is growing fastest as well at 12.76%. The commercial size of that position is USD 0.4 billion in 2025 and USD 1.21 billion by 2034, 3.2% of the global total in the base year.
South Africa
2nd-largest in Middle East and Africa, growing 3.0×.
- In region 2 of 2
- Of region 20%
- Of global 0.6%
- Revenue $0.08B → $0.24B
0.64% of global revenue is generated in South Africa; USD 0.08 billion in 2025, reaching USD 0.24 billion in 2034, and 20% of Middle East and Africa.
Request this sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by component, type, mode of delivery, end user, facility type, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Suppliers Compete on Software Volume and Software Momentum
Suppliers in scope: GetWellNetwork (US), Epic Systems Corporation (US), Cerner Corporation (US), CarePort Health (US), eHealth Technologies, Inc. (US), Optum, Inc. (US), Change Healthcare (US), ReferralMD (US), Kyruus (US), Eceptionist (US), Persistent Systems (India), HealthViewX (US), Conifer Health Solutions, LLC (US), EcoSoft Health (US), DentalCareLinks (US), BlockitNow, Inc. (US), Cloudmed (US), EZ Referral (Canada), ReferWell (US), Arcadia (US), HealthWare Systems (US), Netsmart Technologies, Inc. (US), Advanced (UK), Innovaccer, Inc. (US), Lightbeam Health Solutions (US), MDfit (US), and Medcohere Inc. (US), Allscripts Healthcare Solutions, Inc. and SCI Solutions.
Competition follows the component split, not the regional one. Software is 62.16% of 2025 revenue at USD 7.77 billion and still 66% in 2034, so it is where the volume sits and where an incumbent's position is hardest to move. Software, compounding at 12.76% against 10.67% for Services, is where share changes hands over the forecast period. Those are different problems, and a supplier strong in one is not thereby strong in the other; that is what sustains a field this size in a USD 12.5 billion market.
What separates suppliers in referral management is depth of electronic health record integration: a platform that only connects to one EHR loses to one that works cleanly across a health system's full technology stack. Regulatory and interoperability certification experience, payer network reach, and the ability to support both acute and ambulatory settings from a single platform matter more than brand recognition alone. The largest players compete on integration breadth and payer relationships already built through adjacent claims and care-management businesses. Smaller and regional vendors compete on configurability, specialty-specific workflow design, and hands-on implementation support for practices that a larger platform underserves.
The regional picture sets the entry cost: 57.12% of revenue is in North America and 20% in Europe, so a credible global position requires both, while Middle East and Africa at 3.2% can be served opportunistically.
Per-company profiles, financials, share and development history are in the full report and not here.
List of Key Referral Management Market Companies Profiled
35 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- GetWellNetwork (US)
- Epic Systems Corporation (US)
- Cerner Corporation (US)
- CarePort Health (US)
- eHealth Technologies
- Inc. (US)
- Optum
- Inc. (US)
- Change Healthcare (US)
- ReferralMD (US)
- Kyruus (US)
- Eceptionist (US)
- Persistent Systems (India)
- HealthViewX (US)
- Conifer Health Solutions
- LLC (US)
- EcoSoft Health (US)
- DentalCareLinks (US)
- BlockitNow
- Inc. (US)
- Cloudmed (US)
- EZ Referral (Canada)
- ReferWell (US)
- Arcadia (US)
- HealthWare Systems (US)
- Netsmart Technologies
- Inc. (US)
- Advanced (UK)
- Innovaccer
- Inc. (US)
- Lightbeam Health Solutions (US)
- MDfit (US)
- and Medcohere Inc. (US)
- Allscripts Healthcare Solutions, Inc.(United States)
- SCI Solutions(United States)
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 5 axes (Component, Type, Mode of Delivery, End User, Facility Type), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 35 key companies, and the research methodology behind every estimate.
Segmentation
5 axes + regionFull chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
Chapter 2.Premium Insights
Chapter 3.Market Definition
Chapter 4.Research Methodology
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
Chapter 7.Market Trends, Strategy & Dynamics
Chapter 8.Porter's Five Forces
Chapter 9.PESTEL Analysis
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
Chapter 13.Market Cost Analysis
Chapter 14.Market Supply-Side Analysis
Chapter 15.Global Referral Management Market Size & Projections, 2020–2034, Revenue (USD Billion)
Chapter 16.Global Referral Management Market Overview, By Component, 2020–2034, Revenue (USD Billion)
Chapter 17.Global Referral Management Market Overview, By Type, 2020–2034, Revenue (USD Billion)
Chapter 18.Global Referral Management Market Overview, By Mode of Delivery, 2020–2034, Revenue (USD Billion)
Chapter 19.Global Referral Management Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Chapter 20.Global Referral Management Market Overview, By Facility Type, 2020–2034, Revenue (USD Billion)
Chapter 21.Global Referral Management Market Size — Segment Comparison
Chapter 22.Global Referral Management Geography Overview, 2020–2034, Revenue (USD Billion)
Chapter 23.North America Referral Management Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 24.Europe Referral Management Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 25.Asia Pacific Referral Management Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 26.Latin America Referral Management Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 27.Middle East and Africa Referral Management Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 28.Application / Use-Case Analysis
Chapter 29.Vendor Capability Scorecard
Chapter 30.Scenario Forecasts
Chapter 31.Top 10 Key Clients of Top 10 Players
Chapter 32.Top 10 Suppliers
Chapter 33.Competitive Landscape
Chapter 34.Partnerships & M&A
Chapter 35.Key Vendor Analysis
Chapter 36.Marketing Strategy Analysis, Distributors & Traders
Chapter 37.Outlook of the Market
Chapter 38.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Segmentation Analysis
5 axesBy Component
2- 01Software
- 02Services
By Type
2- 01Inbound Referrals
- 02Outbound Referrals
By Mode of Delivery
2- 01Cloud-based
- 02On-premise
By End User
3- 01Providers
- 02Payers
- 03Other End Users
By Facility Type
3- 01Hospitals & Health Systems
- 02Ambulatory & Specialty Clinics
- 03Diagnostic Centers & Other Facilities
Segment categories shown for scope reference. See the Summary tab for revenue share by By Component. Full segment-by-segment detail across every axis is available in the sample and full report.
Research approach
A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.
The estimate is built upward from the volume of referral transactions processed annually across hospital, clinic and payer networks, combined with the per-seat or per-transaction pricing that software vendors charge and the implementation and managed-service fees billed alongside a deployment. Referral volumes are derived from outpatient visit and specialist-consult counts by region, then priced using disclosed subscription tiers and services rate cards. That bottom-up figure is checked against the health-information-technology revenue lines that public parents such as UnitedHealth's Optum segment and Oracle Health disclose, and against Persistent Systems' healthcare-vertical reporting. Where the two diverge, the referral-volume or pricing assumption feeding the bottom-up build is corrected, not averaged against the check.
The four stages
The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.
What the build rests on, and what checks it
The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.
- Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
- Realised pricing by tier and channel, rather than one blended average applied across the whole market
- Take-up and frequency: how much of the addressable base buys, and how often it repeats
- Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
- Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
- Trade and customs flows, where the product crosses borders in a separately recorded form
Data sources
Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.
- Commercial and product leadership at the companies that supply the market
- Procurement and specification leads at the organisations that buy it
- Distributors, integrators and channel partners, where the market is served indirectly
- Regulatory and standards specialists, where approval governs what can be sold at all
- Company filings, annual reports and investor disclosure
- Government statistics, customs records and regulatory registers
- Trade association output and standards-body publications
- Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Interviews target health system IT directors and referral-coordination leads who own the buying decision, payer network-management executives who evaluate leakage-reduction tools, product and commercial leaders at e-referral platform vendors, and credentialing or regulatory compliance staff who influence procurement timing. Sampling weights toward the United States, where referral coordination platforms are most established and where value-based contracting has pushed adoption furthest, with secondary coverage in the United Kingdom and other markets running national e-referral programs. Conversations focus on deployment scope, pricing structure, contract length and the operational triggers, such as a new payer contract or an EHR migration, that move a health system from evaluation to purchase.
Desk research draws on the ONC Certified Health IT Product List for interoperability and certification status, CMS reimbursement and quality-reporting schedules that shape provider incentives to reduce referral leakage, state health information exchange registries for adoption patterns, and HIMSS interoperability benchmark survey data. Public filings from parent organizations, including UnitedHealth Group's segment reporting for Optum and Oracle's disclosures for Oracle Health, supply revenue and investment context for the largest platform owners. Persistent Systems' own annual filings inform assumptions about services-led delivery. These sources anchor the historical base; none of them report a referral-management category directly, which is why the bottom-up build carries the estimate.
Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.
Forecasting
The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.
The forecast is built from three demand shifts: continued movement of specialist and diagnostic care into ambulatory and outpatient settings, the rollout of FHIR-based interoperability mandates that make automated referral exchange a compliance requirement, and payer adoption of network-management tools to contain out-of-network referral spending under value-based contracts. Pricing is assumed to continue shifting toward subscription and usage-based models as cloud deployment expands. The 2021-2022 surge in telehealth-linked referral volume is normalized out of the base trend rather than extrapolated forward. For the forecast to hold, interoperability mandates need to proceed on their published timelines rather than being delayed.
Triangulation and validation
No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.
Outputs are back-tested against the recorded 2020-2024 growth of e-referral and care-coordination software adoption reported by health systems and by the vendors themselves, to confirm the historical trajectory used as the forecast base is consistent with observed deployment activity. Segment share shifts, particularly the move from on-premise to cloud delivery and the growing share held by payer buyers, are reviewed against publicly discussed contract wins and platform migrations. Sensitivities are tested on referral-volume growth, price realization under subscription pricing, and the pace at which payer network-management budgets expand, to confirm the forecast does not depend on a single assumption holding exactly.
Confidence and limitations
Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.
Confidence is firmest on the split between software and services and between cloud and on-premise delivery, where public vendor disclosures and certification listings give a direct read. It is thinner on the payer end-user segment, where adoption is real but rarely broken out separately, and on Latin America and Middle East and Africa volumes, where fewer vendors report region-specific activity. The main structural risk to the forecast is a delay in interoperability mandate timelines, which would slow the shift toward automated, standards-based referral exchange that the forecast currently assumes proceeds on schedule.
Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.
Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Referral Management Market projected to reach?
USD 34.68 Billion by 2034, CAGR 12.01%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 57.12% of global revenue through 2034.
05Which segment leads the market?
Software is the largest line by component, at 62.16% of revenue in 2025.
06Who are the key companies profiled?
GetWellNetwork (US), Epic Systems Corporation (US), Cerner Corporation (US), CarePort Health (US), eHealth Technologies, Inc. (US), Optum, Inc. (US), Change Healthcare (US), ReferralMD (US), Kyruus (US), Eceptionist (US), Persistent Systems (India), HealthViewX (US), Conifer Health Solutions, LLC (US), EcoSoft Health (US), DentalCareLinks (US), BlockitNow, Inc. (US), Cloudmed (US), EZ Referral (Canada), ReferWell (US), Arcadia (US), HealthWare Systems (US), Netsmart Technologies, Inc. (US), Advanced (UK), Innovaccer, Inc. (US), Lightbeam Health Solutions (US), MDfit (US), and Medcohere Inc. (US), Allscripts Healthcare Solutions, Inc., SCI Solutions. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.